Bacterial cystitis in women.

Department of Urology, Royal Prince Alfred Hospital, New South Wales, Australia.
Australian family physician (Impact Factor: 0.71). 05/2010; 39(5):295-8.
Source: PubMed

ABSTRACT A woman presenting with symptoms suggestive of bacterial cystitis is a frequent occurrence in the general practice setting. One in three women develop a urinary tract infection (UTI) during their lifetime (compared to 1 in 20 men).
In this article we provide an outline of the aetiology, pathogenesis and treatment of bacterial cystitis in the primary care setting. We suggest measures that may assist before urological referral and work through a common clinical scenario.
Bacterial cystitis in unlikely if the urine is both nitrite and leuco-esterase negative. Empirical antibiotics are justified if symptoms are present with positive urinary dipstick, but microscopy, culture and sensitivity of urine is warranted to ensure appropriate empirical therapy and identification of the causative organism. Risk factors for UTI in women include sexual intercourse, use of contraceptive diaphragms and, in postmenopausal women, mechanical and/or physiologic factors that affect bladder emptying such as cystocoele or atrophic vaginitis. Discussion regarding risk factors and UTI prevention is important. Women with recurrent UTIs (defined as three or more episodes in 12 months or two or more episodes in 6 months) should be screened for an underlying urinary tract abnormality (ultrasound) and may benefit from prophylactic therapy. Patients with complex or recurrent UTIs, persistent haematuria, persistent asymptomatic bacteriuria, or urinary tract abnormalities on imaging may benefit from referral to a urologist.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug resistance is becoming alarming with the passage of time worldwide in general and in third world countries in particular. Human urine specimens of patients of urinary tract infection at Sheikh Zayed hospital, Lahore, Pakistan were analyzed for drug resistance in Escherichia coli. A total of 69 Escherichia coli isolates from human urine specimens were obtained and screened for their antibiograms. A total of seven antibiotic resistance profiles were obtained with over 65% of the isolates showing multi-drug resistance. Very high resistance levels were detected against augmentin and gentamicin (87.5 &77.5 % respectively) while imipenem and tazocin recorded the least resistance levels (32.5% and 12.5% respectively) among the isolates.
    Bioinformation 01/2014; 10(7):419-22. · 0.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the clinical outcomes of ertapenem administered as an outpatient parenteral antibiotic therapy for intractable cystitis caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. We retrospectively reviewed a case series of 3 years of therapeutic experience with ertapenem for intractable recurrent cystitis caused by ESBL-producing E. coli. Ertapenem 1 g/d was parenterally administered to the patients on an outpatient basis until the acquisition of symptomatic improvement and negative conversion of urine culture. Demographic and clinical characteristics of patients, antimicrobial resistance, and clinical response data were analyzed from the patients' medical records. During the course of this study, a total of 383 patients were diagnosed with cystitis, and 24 of them showed ESBL-producing E. coli (6.26%). The mean treatment duration of all patients was 8.5 days. The early clinical and microbiological cure rates 0 to 7 days after the end of treatment were 91.7% (22/24) and 90.9% (20/22), respectively. The late clinical and microbiological cure rates 4 to 6 weeks after the end of treatment were 72.2% (13/18) at both time points. Parenteral ertapenem treatment can be an effective and well-tolerated treatment option for intractable recurrent cystitis by multidrug-resistant ESBL-producing E. coli.
    Korean journal of urology 04/2014; 55(4):270-5.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Urinary tract infections are the most common bacterial infections, in the community and in the hospital. The aim of this study was to know the etiology of community-acquired urinary infection in Portugal and the antibiotic susceptibility of its main agents. A total of 1020 urines from ten community-serving clinical analysis laboratories were examined, between February and March 2010. The antibiotic susceptibility profile was tested through disk-diffusion method. fimH, ecpA and papC genes were detected through PCR. 87,45% of urines came from women. Most patients had over 50 years of age. Escherichia coli was the mostfrequent etiological agent (69,71%). Amoxicillin was the antibiotic with the number of resistant isolates (48,92%), followed by trimethoprim/sulfamethoxazol (28,39%) and ciprofloxacin (18,17%), while fosfomycin had the lowest number of resistant bacteria (3,87%). Of the E. coli virulence factors assayed, fimH was detected in 79,41% of the isolates, ecpA in 82,94% and both simultaneously in 49,41%. Antibiotic resistance to trimethoprim/sulfamethoxazol and ciprofloxacin has been increasing, which undermines their use as first-line empirical therapeutic. The choice of adequate empirical antibiotherapy should be based on the knowledge of the local etiology as well as the antibiotic susceptibility profile of uropathogenic bacteria.
    Revista Portuguesa de Doenças Infecciosas. 01/2012; 8(1):7-12.

Full-text (2 Sources)

Available from
Jun 6, 2014